encer
NDC 82509-001, Cadmium sulphuratum, Carbo animalis, Phosphoricum acidum, Radium bromatum, X-ray, tablet, orally disintegrating, from B'OKCARES LTD.
- Product NDC
- 82509-001
- Status
- Listed
- Labeler
- B'OKCARES LTD
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82509-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CADMIUM SULFIDE30 [hp_C]/1
- CARBO ANIMALIS30 [hp_C]/1
- PHOSPHORIC ACID30 [hp_C]/1
- RADIUM BROMIDE30 [hp_C]/1
- ALCOHOL, X-RAY EXPOSED (1000 RAD)6 [hp_C]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82509-001-60 | 82509000160 | 3 BLISTER PACK in 1 CARTON (82509-001-60) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 82509-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82509-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82509-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.